Assessment first
Evidence-aware
Safety focused
Women’s Health Clinic FAQ
How do women with joint hypermobility or Ehlers-Danlos syndrome respond to SUI surgical and non-surgical treatments?
Stress urinary incontinence is influenced by urethral closure, pelvic-floor support, tissue quality and bladder symptoms, so treatment choices should start with the mechanism rather than one isolated factor.
Direct answer
Women with joint hypermobility or Ehlers-Danlos syndrome may respond differently to SUI treatments because connective tissue behaviour, pain sensitivity, healing, prolapse risk and joint control can vary. Conservative care may need specialist pelvic-health input, and surgery requires careful counselling about uncertainty and tissue factors. The diagnosis does not rule treatment in or out by itself; it makes individual assessment and realistic expectations especially important.
A useful consultation separates stress leakage from urgency, infection, retention, prolapse, pain and previous-surgery factors before recommending treatment or self-management.
Educational only. This page is educational and does not replace individual assessment. Results vary. Not a cure.
SUI guidance
At a glance
These points help place the question in a safer clinical context.
At a glance
Clinical summary
Tissue
Connective-tissue behaviour can change pelvic support.
Variation
Response to treatment may be less predictable.
Medication
Steroids should never be changed without the prescriber.
Care
Specialist pelvic-health input may be useful.
Important safety note
Seek medical advice promptly for inability to pass urine, fever, blood in urine, recurrent urinary infection symptoms, severe pelvic pain, new neurological symptoms, postmenopausal bleeding or pregnancy concerns.
Pelvic floor
Tissue
Suitability
Review
Detailed answer
Detailed answer
Connective tissue helps support the urethra, bladder neck and pelvic organs during pressure changes.
Clinical context
Hypermobility, Ehlers-Danlos syndrome or systemic steroid exposure may change tissue resilience, pain, healing or prolapse risk.
Symptoms
Evidence
Alternatives
What is happening
Connective tissue helps support the urethra, bladder neck and pelvic organs during pressure changes.
Why it varies
Hypermobility, Ehlers-Danlos syndrome or systemic steroid exposure may change tissue resilience, pain, healing or prolapse risk.
What assessment checks
These factors do not prove the cause of leakage on their own.
What keeps it safe
Treatment decisions should be individualised and cautious, especially before surgery.
What this means in practice
The page should explain the mechanism without reducing SUI to one cause or promising a single predictable result.
If symptoms are new, severe, mixed, painful, post-operative or pregnancy-related, the plan should pause for medical review.
Patient safety
Why this matters
The same outward leak can have different drivers, and the right next step depends on separating them.
It clarifies the mechanism
Pressure load, tissue quality, sphincter closure, pelvic-floor timing and bladder sensitivity are different issues.
It protects confidence
SUI can affect sport, sex, work, clothing, travel and public life, so it deserves a serious plan.
It prevents over-treatment
Conservative care, medication, surgery or referral suit different people and should not be rushed.
It keeps safety visible
Pain, infection, retention, bleeding, pregnancy concerns or previous pelvic surgery can change the pathway.
An individual plan
The safest approach considers symptom burden, cause, medical history, tissue context, goals and red flags.
This is especially important when medicines, pregnancy, elite sport, connective-tissue disorders or surgery are involved.
Considerations
What to consider
Before deciding what to do, consider the leakage trigger, bladder pattern, pelvic-floor function, bowel symptoms, cough, hormones, medication, pregnancy or surgery history and how symptoms affect daily life.
Consultation priorities
Assessment reviews diagnosis, tissue symptoms, pain, prolapse, previous surgery, medication and bladder pattern.
Triggers
Options
Follow-up
First assessment
Assessment reviews diagnosis, tissue symptoms, pain, prolapse, previous surgery, medication and bladder pattern.
Plan discussion
Conservative care may include specialist pelvic-floor physiotherapy, pacing, support garments or pressure management.
Monitoring response
Surgical or procedural options require careful discussion of uncertainty, healing and recurrence risk.
When to reassess
Medication questions should be handled by the prescribing clinician.
Practical expectations
Improvement varies; review should look at leak triggers, quality of life, comfort, bladder emptying and any new symptoms.
Costs, access, prescription decisions, recovery instructions and treatment details should be confirmed directly with the clinic or prescribing clinician before booking.
Common concerns and myths
Common misconceptions
These myths are common because SUI is often discussed too simply.
Myth: connective tissue explains everything
Reality: bladder, pelvic-floor and pressure factors still need assessment.
Myth: hypermobility rules out treatment
Reality: it changes planning rather than automatically removing options.
Myth: steroid concerns mean stopping medicine
Reality: prescription changes must be clinician-led.
Evidence and context
A claim is only useful when it is matched to the woman's actual leakage mechanism and safety profile.
Alternatives
Options may include pelvic-floor physiotherapy, lifestyle support, containment, medicine review, local tissue treatment, surgery or specialist referral depending on the diagnosis.
Safety checklist
Safety checklist
Use these checks before relying on a single explanation or treatment plan for SUI.
Is the leakage pattern clear?
Stress leakage should be separated from urgency, infection, retention, prolapse, pain and mixed symptoms.
Have pressure factors been reviewed?
Cough, constipation, heavy lifting, training load, weight changes and smoking-related cough may all affect symptoms.
Are red flags absent?
Seek medical advice promptly for inability to pass urine, fever, blood in urine, recurrent urinary infection symptoms, severe pelvic pain, new neurological symptoms, postmenopausal bleeding or pregnancy concerns.
Is follow-up planned?
Know who reviews non-response, side effects, worsening leakage, pain, infection symptoms or difficulty passing urine.
Reassuring signs
Proceeding is more reasonable when the diagnosis is clear, expectations are realistic and follow-up is arranged.
No red flags
Review plan
Reasons to pause
Seek medical advice promptly for inability to pass urine, fever, blood in urine, recurrent urinary infection symptoms, severe pelvic pain, new neurological symptoms, postmenopausal bleeding or pregnancy concerns.
Infection
Severe pain
When to escalate
When to seek medical help
Some urinary or pelvic symptoms should be assessed promptly.
Use NHS 111 online
Unable to pass urine
Inability to pass urine, painful bladder fullness or repeated unsuccessful attempts to void need prompt clinical advice.
Infection symptoms
Fever, burning with feeling unwell, blood in urine, worsening pelvic pain or recurrent UTI symptoms should be assessed.
Pain, bleeding or pregnancy concern
Severe pelvic pain, postmenopausal bleeding, unusual discharge, pregnancy concerns or post-operative deterioration should not be ignored.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why tissue context matters
Urethral support depends on muscle, connective tissue, mucosa, nerves and pressure control. Hormonal or connective-tissue factors can influence this system without being the only cause.How to make the consultation more useful
Bring a symptom pattern, medication list, cycle or menopause notes, exercise triggers and any history of prolapse, surgery, pain or recurrent infection.Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware SUI information.
NICE NG123 urinary incontinence recommendations
NICE anchors assessment, conservative care and complex treatment decisions for SUI.
NICE NG210 pelvic floor dysfunction recommendations
NICE supports pelvic-floor dysfunction assessment and non-surgical management.
NHS urinary incontinence symptoms
NHS gives accessible patient context for stress leakage and when to seek medical help.
Next step
Book a continence consultation
A consultation can clarify the SUI mechanism, review conservative and specialist options, and decide what is safe and realistic for your situation.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 312 curated sources. Additional reviewed material included professional society guidance, peer-reviewed clinical papers, evidence reviews; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
